These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 23919601)

  • 1. Eosinophil-targeted therapy: not the panacea for antibody-mediated rejection?
    Kers J; Florquin S
    Am J Transplant; 2013 Oct; 13(10):2522-3. PubMed ID: 23919601
    [No Abstract]   [Full Text] [Related]  

  • 2. A case for APRIL/BLyS directed therapy not eosinophil directed therapy for alloantibody elimination.
    Redfield RR; Abt PL; Naji A
    Am J Transplant; 2014 Feb; 14(2):492-3. PubMed ID: 24320568
    [No Abstract]   [Full Text] [Related]  

  • 3. Eosinophils are not required for the induction and maintenance of an alloantibody response.
    Cravedi P; Lessman DA; Heeger PS
    Am J Transplant; 2013 Oct; 13(10):2696-702. PubMed ID: 23919628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No strict requirement for eosinophils for bone marrow plasma cell survival.
    Bortnick A; Chernova I; Spencer SP; Allman D
    Eur J Immunol; 2018 May; 48(5):815-821. PubMed ID: 29442367
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subclinical antibody-mediated rejection due to anti-human-leukocyte-antigen-DR53 antibody accompanied by plasma cell-rich acute rejection in a patient with cadaveric kidney transplantation.
    Katsuma A; Yamamoto I; Komatsuzaki Y; Niikura T; Kawabe M; Okabayashi Y; Yamakawa T; Katsumata H; Nakada Y; Kobayashi A; Tanno Y; Miki J; Yamada H; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():31-4. PubMed ID: 26971538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 5 immunotherapy depletes alloreactive plasma cells.
    Redfield RR; Rodriguez E; Luo Y; Rostami S; Parsons RF; Noorchashm H; Abt PL; Naji A
    J Surg Res; 2014 Mar; 187(1):310-5. PubMed ID: 24267616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late acute antibody-mediated rejection differ immunologically and in response to proteasome inhibition.
    Walsh RC; Brailey P; Girnita A; Alloway RR; Shields AR; Wall GE; Sadaka BH; Cardi M; Tevar A; Govil A; Mogilishetty G; Roy-Chaudhury P; Woodle ES
    Transplantation; 2011 Jun; 91(11):1218-26. PubMed ID: 21617586
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Eosinophils are not essential for maintenance of murine plasma cells in the bone marrow.
    Haberland K; Ackermann JA; Ipseiz N; Culemann S; Pracht K; Englbrecht M; Jäck HM; Schett G; Schuh W; Krönke G
    Eur J Immunol; 2018 May; 48(5):822-828. PubMed ID: 29442374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Eosinophils from lineage-ablated Delta dblGATA bone marrow progenitors: the dblGATA enhancer in the promoter of GATA-1 is not essential for differentiation ex vivo.
    Dyer KD; Czapiga M; Foster B; Foster PS; Kang EM; Lappas CM; Moser JM; Naumann N; Percopo CM; Siegel SJ; Swartz JM; Ting-De Ravin S; Rosenberg HF
    J Immunol; 2007 Aug; 179(3):1693-9. PubMed ID: 17641035
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Plasma cell-eosinophil interaction].
    Berek C; Chu VT
    Z Rheumatol; 2013 Apr; 72(3):267-9. PubMed ID: 23503783
    [No Abstract]   [Full Text] [Related]  

  • 11. Fractionation of mature eosinophils in GATA-reporter transgenic mice.
    Kim K; Suzuki N; Ohneda K; Minegishi N; Yamamoto M
    Tohoku J Exp Med; 2010 Feb; 220(2):127-38. PubMed ID: 20139664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A suspected case of plasma cell-rich acute renal transplant rejection associated with de novo donor-specific antibody.
    Yoshikawa M; Kitamura K; Ishimura T; Hara S; Fujisawa M; Nishi S
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():66-9. PubMed ID: 26031590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GATA transcription factors regulate the expression of the human eosinophil-derived neurotoxin (RNase 2) gene.
    Qiu Z; Dyer KD; Xie Z; Rådinger M; Rosenberg HF
    J Biol Chem; 2009 May; 284(19):13099-109. PubMed ID: 19279013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Follicular Helper T Cell Derived Exosomes Promote B Cell Proliferation and Differentiation in Antibody-Mediated Rejection after Renal Transplantation.
    Yang J; Bi L; He X; Wang Z; Qian Y; Xiao L; Shi B
    Biomed Res Int; 2019; 2019():6387924. PubMed ID: 31223621
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-mediated rejection of the pancreas allograft.
    Torrealba JR; Odorico J
    Transplantation; 2009 Jul; 88(2):292-3. PubMed ID: 19623030
    [No Abstract]   [Full Text] [Related]  

  • 16. Plasma Cell-Rich Rejection After Kidney Transplantation and the Role of Donor-Specific Antibodies: A Case Report and Review of the Literature.
    Hasegawa J; Honda K; Wakai S; Shirakawa H; Omoto K; Okumi M; Ishida H; Tanabe K
    Transplant Proc; 2015 Oct; 47(8):2533-6. PubMed ID: 26518965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between blood eosinophil counts and acute cardiac and pulmonary allograft rejection.
    Trull A; Steel L; Cornelissen J; Smith T; Sharples L; Cary N; Stewart S; Large S; Wallwork J
    J Heart Lung Transplant; 1998 May; 17(5):517-24. PubMed ID: 9628572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms involved in antibody- and complement-mediated allograft rejection.
    Wasowska BA
    Immunol Res; 2010 Jul; 47(1-3):25-44. PubMed ID: 20135240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dimensions of antibody-mediated rejection.
    Colvin RB
    Am J Transplant; 2010 Jul; 10(7):1509-10. PubMed ID: 20642676
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heart transplantation. Pathology, clinical work-up and therapy].
    Baba HA; Wohlschläger J; Stypmann J; Hiemann NE
    Pathologe; 2011 Mar; 32(2):95-103. PubMed ID: 21305380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.